Bluebird bio Halts Sickle Cell Trials After Leukemia Diagnosis

, , , , , , , ,

Bluebird bio placed the company’s Phase I/II and Phase III trials of LentiGlobin gene therapy for sickle cell disease (SCD) on temporary suspension.

Read more
/by